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Background: The increasing burden of chronic disease is recognised globally. Within the English National Health
Service, patients with chronic disease comprise of half of all consultations in primary care, and 70% of inpatient bed
days. The cost of prescribing long-term medications for those with physical chronic diseases is rising and there is a
drive to reduce medicine wastage and costs. While current policies in England are focused on the latter, there has
been little previous research on patient experience of ordering and obtaining regular medication for their chronic
disease. This paper presents findings from England of a qualitative study and survey of patients and their carers’
experiences of community and primary care based services for physical chronic diseases. Although not the primary
focus of the study, the results highlighted particular issues around service delivery of repeat prescriptions.
Methods: We conducted 21 qualitative in-depth interviews with 30 patients and family carers’ in two Primary Care
Trusts in England. Participants were receiving community based care for diabetes, respiratory, neurological or
complex co-morbidities, and ranged in age from 39–92 years old. We used a broadly inductive approach to enable
themes around patient experience to emerge from the data.
Results: While the study sought to gain an overview of patient experience, the findings suggested that the
processes associated with ordering and obtaining regular medication – the repeat prescription, was most frequently
described as a recurring hassle of managing a long-term condition. Issues for patients and carers included multiple
journeys to the surgery and pharmacy, lack of synchrony and dissatisfaction with the length of prescriptions.
Conclusion: Much literature exists around medication waste and cost, which led to encouragement from the NHS
in England to reduce dosage units to a 28-day supply. While there has been an acknowledgement that longer
supplies may be suitable for people with stable chronic conditions, it appears that there is limited evidence on the
impact of shorter length prescriptions on patient and carer experience, adherence and health outcomes. Recent
policy documents within England also fail to address possible links between patient experience, adherence and
flaws within repeat prescription service delivery.
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Chronic diseases are the major challenge facing the glo-
bal health economy. The World Health Organization es-
timates that non-communicable diseases account for
more than 60% of deaths worldwide [1]. Within the
United States it is predicted that five long-term condi-
tions (cardiovascular disease, cancer, chronic respiratory
disease, diabetes, mental health) will cause a cumulative
output loss of US$ 47 trillion over the next twenty years
[2]. Around 15 million people in England have a long-
term condition [3]. The number of chronic diseases per
person increases with age [4], and these patients are the
most frequent users of healthcare services. In England
and Wales, patients with chronic disease account for
50% of General Practitioner (GP) appointments and 70%
of all inpatient bed days [5]. Currently the flow of pol-
icies is aimed at integrating services for long-term condi-
tions and enabling patient choice and voice in service
provision [6,7]. Alongside the move towards a more
seamless approach to service provision, medicines man-
agement continues to play a significant role within
chronic disease management. The National Health Ser-
vice (NHS) in England spent £8.2 billion on prescription
drugs in primary care in 2006, around a quarter of the
total expenditure on primary care. Ninety-eight per cent
of these drugs were prescribed by GPs [8], with 12 of the
20 most frequently prescribed medications being for
chronic diseases. Drugs for cardiovascular disease are
the most commonly dispensed and cost the NHS £1.9
billion in 2006 [9].
Within the English NHS, the majority of patients with
chronic diseases are over the age of 65 and are pre-
scribed drugs with no charge to the patient, with older
people receiving an average of 38 items per year [8]. In
England, regular medication for stable long-term condi-
tions is normally managed via a repeat prescription
process, whereby prescriptions are issued without a con-
sultation but are regularly reviewed by the GP [10]. The
use of repeat prescriptions has vastly increased over the
past 30 years, reflecting changing morbidity patterns and
the introduction of computerised systems. Recent figures
indicate that 80% of all prescription items dispensed in
primary care are through repeat prescriptions [11], with
repeat prescribing increasing with the age of the patient
[12,13]. While there is general guidance for good prac-
tice in repeat prescribing within the NHS [14] several
models exist for obtaining repeat prescriptions including
patients submitting requests in person, by post, via email
or the telephone, with GP practices often adopting a var-
iety of methods [10]. There have been some attempts at
providing an alternative model to the repeat prescription
process in England. Introduced in 2005, repeat dispensing
enables community pharmacists to dispense regular medi-
cines to patients on each occasion a repeat is needed,without requiring another prescription from their GP. The
GP can sign for up to 12 months of repeat prescription
forms, lasting 28 days each time [15-17]. Despite some
evidence that this provides a more flexible approach for
patients with fewer trips to the GP practice [18] it also
commits them to return to the same pharmacist every
month giving rise to potential problems if a particular
drug is out of stock [16,19]. In reality, repeat dispensing
schemes are relatively rare with the repeat prescription the
most common approach in long term conditions [8].
Internationally, there has been considerable interest in
the health outcomes implications of non-adherence to pre-
scribed medication in chronic conditions [20], and costs
associated with unused medications [21-24]. However, the
preoccupation with the link between non-adherence and
drug wastage has overshadowed exploration of patient ex-
perience around obtaining their prescription and the pos-
sible consequences for adherence. This paper reports on a
study that investigated patient experience of receiving
health care from long term conditions services that had
“integrating activities” [25] such as pathways of care that
cross hospital and community health care providers. A
focus on patient and carer experience allows exploration
of whole systems of care [26] and may also reveal issues
that were previously hidden to service providers and re-
searchers [27]. The aim of the paper is to present the key
themes emerging from interviews with patients and carers
and predominantly concerned medicine management.
Methods
The study was conducted between 2010–2012 and had
built on an earlier mapping of the evidence [28] which
found that services promoting integrated and coordi-
nated care were relatively new, with no clear evidence
on a number of outcomes including patient experience.
Therefore, the main research question was ‘what is the
impact on patient experience of long-term conditions
services with integrating activities?’
In view of the dearth of evidence, a broadly inductive
approach was undertaken to enable themes around pa-
tient experience to emerge from the data, rather than
discarding any themes that did not fit with a precon-
ceived framework. This paper reports findings from
phase two of the study, but in total the study comprised
of three phases. Phase one comprised of a web based
scoping of long term conditions services within two
counties in England which enabled identification of ser-
vices that had “integrating activities” [25,29], for example;
integrated teams or shared clinical processes such as path-
ways of care. We then approached the Primary Care
Trusts (PCT) (the NHS organisation responsible for
commissioning health services within a geographical area)
within the counties and two agreed to participate in the
study (equating to a total patient population of nearly
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of demographics, ethnic and cultural populations, and
rural/urban communities. Both PCTs provided services
for diabetes, respiratory, long-term neurological condi-
tions and older people with complex co-morbidities
(Table 1). Following NHS Research Ethics (REC reference
09/H0302/1) and relevant research governance approval
we invited all lead practitioners, managers and the com-
missioners of the services to participate. With the aim of
gathering in-depth data about each service and percep-
tions of enablers and barriers to integrated working, we
interviewed a total of 16 health professionals. Within
phase two, the lead practitioners from each service distrib-
uted an invitation to a census sample of their patients over
a 1 month period. In the case of the community matron (a
community nurse with additional training in diagnostic
skills and independent prescribing, usually adopting a case
management approach) and respiratory services, this was
to all patients and their family carers who were on the
practitioner’s caseload at that time. For the diabetes and
neurological services, the invitation was given to all pa-
tients who attended the clinic during that month. If inter-
ested in participating, the patient or carer directly
contacted the research team via an expression of interest
form and pre-paid envelope. The lead researcher (PW)
then contacted the patient or carer, went through the in-
formation sheet and answered any questions. If still agree-
able, a date was made for a face to face interview whichTable 1 Community based chronic disease services
Complex needs case
management model
Respiratory service
Site A Site A
Community Matron model. Led by respiratory nurse consultant
with a team of nurse specialists,
physiotherapists, and administration
support.
Model adapted from
United Health.
Medical consultant input though
local and neighbouring acute hospitals.
Co-located with intermediate
care teams.
Loosely attached to GP practices.
Site B Site B
Integrated Community Team. Covers all respiratory diseases and
oxygen reviews.
One team per the three
PCT localities.
Teams include community
matron (case manager), district
nurses, and therapists.
Led by a respiratory nurse consultant
and team of nurse specialists and
a physiotherapist.
Community matron &
district nurses also attached
to GP surgeries.
Provide pulmonary rehabilitation.took place in the patient’s home, with signed informed
consent forms being completed before the interview com-
menced. Interviews were conducted by PW and EM who,
as university based researchers, had no role in the care of
the patient or carer. Good Clinical Practice (GCP) guide-
lines [30] were followed including ensuring participants’
anonymity and maintaining confidentiality. A total of 30
patients and family carers agreed to participate, and of
these 18 participants were interviewed as a dyad (9 inter-
views) and the remaining 12 participants were interviewed
individually. A breakdown of the participants is given in
Table 2. While a topic guide (Table 3) was used to elicit
views and experiences of service delivery and the long-
term conditions, interviews followed a conversational style
[31]. Interviews were recorded, transcribed and coded the-
matically [32], with NVivo software [33] being used to or-
ganise the data. Analysis of data was undertaken both
within and between each long-term condition service, with
at least 2 researchers independently cross-checking coded
transcripts to enable inter-rater reliability. Interviews con-
tinued until data saturation was achieved [34]. This was
established when no new codes were identified in the last
batch of transcripts and there was agreement within the
team that the data collection at that point was not adding
anything new to the exploration of patient experience of
long-term conditions services with integrating activities.
To ensure rigour and to inform the phase three develop-
ment of a pilot questionnaire aimed at measuring patientNeurological service Diabetes service
Site A Site A
Team of nurses and
therapists.
Managed by a nurse consultant under a
single budget with a number of diabetes
nurse specialists.
Work with patients from
diagnosis to end of life.
Provides community based clinics,
education for GPs and practice nurses,
structured self-management education.
Patients refer themselves
in and out of the service
as required.
Site B Site B
3 specialist nurses. 1 diabetes nurse specialist and
1 Diabetes Practitioner Consultant.
22 bedded stroke and
neurology rehabilitation unit.
Structured self-management programme
is provided
Diabetes Nurse Specialist runs clinics in
2 GP centres.
Table 2 Participant description
Participants interviewed Age group Number of
prescribed
medications
In paid
employment
Male with comorbidities (Ischaemic Heart Disease, stroke, arthritis) & wife (carer) 80 plus > 3 Retired
Male with comorbidities (emphysema, arthritis) & wife (carer) 80 plus > 3 Retired
Male with comorbidities (Chronic Obstructive Pulmonary Disease,
Ischaemic Heart Disease, stroke) & wife (carer)
80 plus > 3 Retired
Female with comorbidities (stroke, emphysema, Ischaemic Heart Disease) &
husband (carer) (Ischaemic Heart Disease)
80 plus > 3 Retired
Carer (wife) of man with comorbidities (emphysema, heart failure) 80 plus > 3 Retired
Female with comorbidities (Parkinson’s Disease, osteoporosis, hypertension) &
husband (carer) (Ischaemic Heart Disease)
80 plus > 3 Retired
Female with comorbidities (asthma, heart failure, osteoporosis) 75-79 > 3 Retired
Female with comorbidities (Chronic Obstructive Pulmonary Disease,
osteoarthritis, osteoporosis) and husband (carer) (Ischaemic Heart Disease)
75-79 > 3 Retired
Female with emphysema and hypertension 70-74 > 3 Retired
Male with comorbidities (diabetes type 2, Chronic Obstructive Pulmonary Disease,
Ischaemic Heart Disease, arthritis) & wife (carer)
70-74 > 3 Retired
Female with comorbidities (emphysema, rheumatoid arthritis, atrial fibrillation)
and husband (carer) (Ischaemic Heart Disease, depression)
70-74 > 3 Retired
Male with Parkinson’s Disease & wife (carer) 60-64 > 3 Retired
Female with Parkinson’s Disease 60-64 > 3 Retired
Male with diabetes type 1 60-64 > 3 Retired
Male with diabetes type 2 55-59 > 3 Yes
Male with diabetes type 2 55-59 > 3 No
Female with diabetes type 2 55-59 > 3 No
Female with Parkinson’s Disease 50-54 > 3 No
Male with diabetes type 1 50-54 2 Yes
Female with multiple sclerosis 40-44 0 No
Male with diabetes type 1 35-39 2 Yes
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themes and the research team’s understanding was
checked with participants. Participants from phase two
also undertook test-retesting of the questionnaire before it
was piloted with a separate sample. The study methods
have been presented following the RATS guidelines
(http://www.biomedcentral.com/ifora/rats).
This paper reports on the qualitative findings from pa-
tients and carers in phase two of the study.
Results
Patients and carers did not talk in terms of “coordination”
or “integration” of services. Rather, their focus was on
what features of a service reduced the workload of living
with a long term condition and made life simpler.
Services that made life simpler
Patients and carers receiving the community matron ser-
vice had complex needs and were generally older than
other respondents. They described how the communitymatron took over many aspects of the workload such as
sorting out prescriptions, referring onto and obtaining
rapid access to other services, being a mediator between
all other services, and providing a sense of security
which reduced anxiety.
…she (CM) does my blood pressure, sounds my chest,
any worries, just no worries at all, I mean…It’s general
enquires, i.e., there’s no cure but we’ll give you as much
relief as we can and that’s…Yes. That’s it basically isn’t
it, yes. So I mean she’s (CM) quite good…
“Alice” (emphysema) and “Donald” (carer)
There was also some evidence that the community ma-
tron (CM) service was reducing patient visits to the GP.
I’ve never requested to see a doctor, I just usually ring
up “can I make an appointment to see (CM)?” Well
they should all be working together. And she’s (CM)
Table 3 Interview guide
Topic area Prompts
Tell me a little about yourself Your age?
What occupation you are currently or were previously in?
Your/the person you care for health problems?
How long you/the person you care for have had these problems?
What medications do you/they take?
Tell me about the services you/the person you care for receives Nature and frequency of Health services – primary care, community
services, hospital, rehabilitation, pharmacy, other.
Social services – home care, day centres, other.
Voluntary services – for example; meals on wheels, day centres.
In your opinion how well do these services work together to
coordinate the care?
Can you give me some examples?
How often do you have to tell the same information to several services? Can you give me some examples?
How often do the services seem aware of what the others are doing
for you/the person you care for?
Can you give me some examples?
Is there anything else you would like to tell me about the services
you receive?
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me to see a doctor, “I’ll get a doctor in to see you”,
“Stan” (emphysema, arthritis) and “Mary” (carer)
The respiratory services were also spoken of in positive
terms by patients. Again, these respondents were from the
older age and of importance to them was ease of access to
the service, particularly the nurse consultant (NC).
(NC) … changed two of my sprays … Which made a
big difference but I think the main thing is that I had
always got antibiotics and steroids here so I know that
I can start on them if I feel bad, I haven’t got to wait
for an appointment and I ring (NC) up and (NC)
comes down.
“Lily” (Chronic Obstructive Pulmonary Disease,
osteoarthritis, osteoporosis)
The neurological service was also well evaluated by
service users who ranged in ages and were living with ei-
ther Parkinson’s disease or multiple sclerosis. For them,
what was important was the comprehensiveness of a ser-
vice which included rehabilitation and social care sup-
port, plus being able to self-refer back to the service as
required.
They (Neurological service) make you feel looked after
and considered, you know, they make you feel sort of
as if they’re caring about you, and that’s obviously
clearly just the way the system works, the way it does
dovetail together I think really, it made you feel likeyou weren’t being fobbed off or anything like that, you
know, just basically you felt looked after really …
you’ve always got that security haven’t you, you feel
like you could sort of just give them a ring…that’s a
nice feeling you know.
“Nicola” (multiple sclerosis)
Issues with services
Services that were perceived to be personalised, gave a
sense of being cared for, and provided a sense of security
were described positively by respondents. However, the
data also indicated that a number of service users felt
there was a lack of coordination between the different
aspects of the services they were receiving. Examples in-
cluded blood test results not being transferred between
services, and the need to repeatedly give their health his-
tory to different clinicians. Some respondents with more
than one condition also described issues around being
“separated” into diseases within the clinic/practice-based
clinic.
I go down to (nurse practitioner running the GP based
clinic) and she says ‘Oh, only one thing this time, we’re
only here for so-and-so’, and I’ve got a list…
“Fred” (Diabetes type 2, bladder cancer, hypertension,
atrial fibrillation)
For Fred and his wife this meant that they would have
to make a number of separate appointments to address
all his needs and making the appointment was equally
challenging.
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surgery, then getting an appointment. It seems that if
you can go online, but I don’t like using a computer…
I don’t want computers.
Hassles of living with a long-term condition
The biographical discussion at the beginning of each
interview suggested that patients and carers were pre-
occupied with the “hassle” of living with a long-term
condition with narratives focused on how services could
reduce it. Within this paper we use Lazarus’ definition
of a hassle being “experiences and conditions of daily liv-
ing that have been appraised as salient and harmful or
threatening to the endorser’s well-being” (p376) [35]. In-
cluded within these hassles was dealing with the conse-
quences of fatigue, immobility or the difficulties in
managing cumbersome equipment.
It’s taking the oxygen everywhere, this is the biggest
thing probably. It’s okay taking bottles but you’ve got
that big machine so you’ve got to lift that in and out
the car. As you get older it’s, it doesn’t get easier does
it?…we’ve given up on holidays now really, haven’t we?
“Donald” (carer)
Patients and carers’ descriptions of the challenges they
faced on a daily basis could largely be linked to the con-
sequences of the condition they were living with. How-
ever, irrespective of the age or predominant long-term
condition of each respondent there appeared to be a com-
mon hassle which was raised by respondents themselves,
often during the closing stage of the interview where they
were invited to say anything else about the services they
received not already covered within the interview.
The repeat prescription – a recurring hassle
Even for those patients whose condition had minimal
impact on their daily life, there was a recurring hassle
that the majority of respondents reported; the repeat
prescription. Liam was a younger man with type 1 dia-
betes mellitus. While he was generally positive about his
experience of services, he also described his issues with
managing his prescription.
…I find it a little bit frustrating at times because it’s
all repeat stuff and then occasionally things won’t be
in and I have to chase them…I get frustrated with on
occasions if I’m running low on, whatever it is,
needles or insulin, and I’m chasing and they say “Oh,
won’t be in till Monday” …so that’s probably my only
real, sort of, bugbear.
“Liam” (Diabetes type 1)While the pharmacy not having stock available was
commonly reported, the main problem appeared to be
the amount of time not only spent on returning to the
pharmacy once items came into stock, but also the extra
time it took to manage prescribed medicine that was not
synchronised.
I’ve got two pages of repeat prescriptions and goodness
knows what, and they’re not, they don’t all fall at the
same time, you know, so I spend an awful lot of time…
“Kath” (Emphysema)
Many patients such as Kath managed this issue cov-
ertly rather than asking for a review of her medication.
…sometimes I know that I’ve got perhaps three or
four things to get and there’s another one which I
know I’ll have to in a week’s time, so I’ll say to the
receptionist “look I know this isn’t due yet but to save
me” … But you couldn’t do it with all of the
prescriptions, you know, just the odd one.
“Kath” (Emphysema)
On questioning, none of the participants we inter-
viewed remembered receiving a medication review from
their pharmacy. There was also evidence that they did
not see the pharmacist as having a significant role on
medicines management.
…there’s forty things on his repeat prescription and my
three as well… And do you have to order them once a
month?…No, it doesn’t work out, they never all run out
at the same time…And has the chemist (pharmacist)
said “oh let’s try and get this all sorted out for you”?
I don’t see how they could because some are for two
months, some are for a month, some, you know?
“Mary” (carer)And does the chemist offer you a medicines review?
Doctor does that doesn’t he? No, the doctor, looks
through my tablets whenever they do, you know.
“Sydney” (Diabetes type 2)
Alex and his wife described the effort required in mak-
ing the repeat prescription more manageable.
The prescription. That’s just the sort of thing that you
could really do without when you’ve got this
condition… …I wrote clearly on my request, ‘Please
can I have two months supply of L-Dopa’, because it
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in synchronisation with the rest…I’ve got a maths
degree…but when I asked the doctor for two months
when she first prescribed it, she said ‘Oh, okay, I’ll
give you two months, that’s 90 tablets’, and this is
where the illness is annoying, because I was still able
to work out that a month being roughly 30 days, 3
tablets a day, that’s only one month, and I sort of said
‘That’s only one month’. She said ‘No, no, that’s two
months’, and I panicked a bit and I didn’t follow the
argument through that it should have been 180.
“Alex” (Parkinson’s disease)
In one extreme case, Jeff with heart disease cared for his
wife Mabel with rheumatoid arthritis, emphysema, atrial
fibrillation and inflammatory bowel disease. They were
both on multiple medications and were registered with dif-
ferent practices. Jeff described how he took the repeat re-
quests to each surgery, returning two days later to pick
them up and deliver to the pharmacy. When collecting the
prescriptions he was frequently told by the pharmacist that
he cannot dispense certain drugs for Mabel because of
interaction alerts, with Jeff being asked to return to Mabel’s
GP to query this. As for a number of other respondents,
managing the repeat prescription proved to be one of the
most demanding tasks on a week-by-week basis. This ex-
ample illustrates the complexity of medication manage-
ment coupled with a divided system between prescriber
and dispenser that left the carer feeling unsupported.
The majority of patients we interviewed were on an
established drug regimen (Table 2), but prescriptions
only lasted 28 days. Although many respondents reported
difficulties with the repeat prescription, there were some
notable exceptions.
Seamless repeat prescription systems
Different models of prescribing and dispensing repeat
prescriptions were described. There were examples of
the community pharmacy providing a service which re-
moved any effort on the patient’s part in managing the re-
peat prescription, with the pharmacy ordering, dispensing
and delivering the medicines to the patient’s house.
Despite having co-morbidities and complex needs, pa-
tients and carers receiving the community matron service
did not report issues around their repeat prescriptions.
Their narratives included accounts of the community ma-
tron organising seamless prescribing, medication review
and delivery of the prescription that negated this particular
hassle of living with chronic conditions.
We hadn’t appreciated the depth of the Community
Matron’s, sort of, the sweep of her thing… she can
call in more things than we thought, we thought shewas just coming round to check on how we were, but
apparently she can control quite a few things like our
prescriptions.
“Arthur” (carer)
However, for many the time involved in submitting
prescription requests in person, picking up the script,
delivering to the chemist and then returning a few days
later only to find that a number of items were out of
stock proved to be the final irritation in negotiating long
term conditions care delivery. Problems were exacer-
bated when the prescription only lasted 28 days meaning
that the cycle of ordering, picking up, delivering and
picking up was repeated more frequently.
Discussion
The aim of this study was to explore patient experience
of long-term conditions services which had elements of
integration and were aiming to provide a seamless ser-
vice. Our interview guide (Table 3) allowed participants
to raise any examples of where care felt fragmented. The
results suggest that fragmentation manifested itself in
patient experience as labour-intensive challenges in the
management of their condition, such as accessing GP
appointments, but most predominantly in managing
their repeat prescription. Corbin & Strauss [36] describe
trajectory work as the activities a person does to manage
their chronic illness. In this study emblematic of “trajec-
tory” work was the effort required to ensure prescribed
medication was available in the home. It appeared that
this work was increased if repeat prescriptions were re-
quired every month rather than a longer period. The
majority of patients and carers interviewed found man-
aging repeat prescriptions a time consuming task, causing
disruption to life. Reasons for this included having to make
several journeys per prescription including the initial re-
quest and subsequent collections. Lack of synchrony was
reported with medications finishing at different times; this
in turn increased the number of visits to the surgery.
For the relatively few patients’ who did not report any
difficulties with their repeat prescriptions, their repeat
prescription requests to the GP were linked directly to
the pharmacy, from where patients’ could collect their
medication, or it was delivered to their home address.
Similarly, patients receiving services where the repeat
prescription was organised on their behalf, such as the
community matron service, did not report any issues
arising from their repeat medication.
However, in reality many patients and carers found
themselves significantly deviated from the clear route map
for repeat prescriptions as presented in the Good Practice
Guide to Quality Repeat Prescribing [14] (Figure 1), with
their actual experience a more difficult route (Figure 2).
Patient sees 
prescriber
Need for repeat 
medication 
identified.
Repeat 
prescription 
authorised.
Request for 
repeat 
submitted
Prescription 
collected by 
patient or 
representative
Patient decides to 
reorder medication
Medication 
received by 
patient
Medication review, 
prescription issued
Prescription 
received by 
pharmacy
Medication used 
by patient
Figure 1 Repeat prescription ideal route map.
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of obtaining prescriptions. A review of the evidence
around older people and medicine management high-
lighted a number of studies that suggested reasons for
poor medication adherence in older people including;
health beliefs, therapy related factors and some system
and health care team related factors such as the pack-
aging and labelling of medicines [37]. However, a na-
tional survey and interview study within England
reported that family carers experienced difficulties in
maintaining a continuous supply of medications for the
person they cared for [38]. These difficulties included the
increased burden of making repeated visits to the GPDifficulties in 
making 
appointment 
with GP
Unable to see 
same 
GP/prescriber
Repeat 
prescription 
authorised.
Difficulties 
submitting 
Patient decides to 
reorder medication
Difficulties
review. D
any chang
Figure 2 Recurring hassles of the repeat prescription.surgery to sort out any problems with the repeat prescrip-
tion; however no link was made to the length of prescrip-
tion. A report by AT Kearney commented on patient
expectations of pharmacies [39]. A significant proportion
of patients stated that pharmacy opening hours did not suit
their lifestyle needs, and also that waiting times for pre-
scriptions were too long [39]. Our findings suggest that
many of the patients interviewed were dissatisfied with the
length of their repeat prescription. Much literature exists
about the cost, length and wastage of medicines. The
National Health Service spends £8 billion a year on pre-
scription drugs in primary care in England. Expenditure on
primary care drugs has increased by 60 per cent over thein 
request
Difficulties in 
collecting 
prescription
 in making appointment for  
ifficulties in informing GP about 
es in medications
Difficulties in 
taking 
prescription to 
pharmacy. 
Pharmacy out 
of stock
Difficulties in 
getting to 
pharmacy to 
pick up 
prescription
Medicines not 
synchronised, some 
run out before others
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creased by 55 per cent [8,23]. It is estimated that up to
£300 m is wasted (medicines dispensed but not consumed)
in NHS primary and community care prescription drugs in
England annually, and that £150 m of the medicines waste
is avoidable [23]. The National Audit Office published a re-
port in 2007 criticising the prescribing of doctors and levels
of pharmaceutical waste [8], estimating that cost of waste
varies from 1% to 10% of total spending on medicines
[40,41]. As a response to the rising cost of medicine
waste, Primary Care Trusts, with the encouragement of
the National Prescribing Centre, introduced initiatives
to reduce the number of dosage units to a 28-day supply
[8,41,42]. The effect of these initiatives is clear with a
2008 study indicating that the average length of a pre-
scription was 40 days [40], whereas a recent study
looking at trends in prescribing data from 1998 – 2009
in England for 11 medicines showed a significant drop
in doses per prescription. However, this equated to 35
million more items being dispensed in 2009 compared
to 1998. It is estimated that this cost the NHS an extra
£150 m a year in dispensing fees [41].
There is evidence of patient organisations lobbying for
changes to prescription length. The Patients Association
argued that the majority of patients are unhappy with a
28-day supply of medicines; one reason for this is the
rise in cost for the patient. Patients with long-term con-
ditions need multiple prescriptions, paying prescription
charges more often [42]. In an open letter to the Depart-
ment of Health [43], the Addison’s Disease Support
Group stated that reducing prescriptions to 28 days is
disempowering for patients, causing anxiety when run-
ning low, particularly over weekends. It also limits the
freedom to travel.
There is limited previous research exploring the effect
of prescription length. A UK survey [44] looking at
trends in the prescribing of thyroid hormone medication
showed that prescription duration over the last 10 years
has reduced from 60 to 45 days on average. The survey
showed great dissatisfaction with the 28-day prescription
(59% dissatisfied overall, 13% satisfied). Fewer than half
of those given a 28-day prescription had asked their GP
for a greater supply. Of concern is that 17% admitted to
missed medication, 6% having gone without tablets on
more than one occasion owing to lack of dispensed
medication [44]. However, some patients thought ob-
taining repeat prescriptions would be easier to remem-
ber if all the medicines were given for 28 days, and
would improve synchrony. It allows for production of a
28-day “blister pack” which makes it easier for patients
to remember medication [44].
The National Prescribing Centre in 2008 released fur-
ther information regarding the 28-day policy, advising
that longer prescription periods may be suitable forthose patients who suffer with long-term conditions and
can safely manage their medication [18]. Despite this ad-
vice, prescribers routinely write prescriptions for 28 days
[18,41,44]. A recent report commissioned by the Depart-
ment of Health [11] made no explicit mention of the im-
pact of prescription length, but focused on the link
between improved repeat prescribing, improved health
outcomes and reduced dispensing of medicines that
were no longer required. However, while the report
recommended improved communication with patients
about prescribing decisions, it did not identify the need
for improving mechanisms for feedback from patients
about their experiences of repeat prescription services.
There are several advantages and disadvantages to a
28-day prescribing policy. However there is very little
previous evidence evaluating how this change in pre-
scribing behaviour has impacted upon patients. Up to
now, patient experience has played little part in the
wastage versus prescription cost debate, but with an in-
creasing focus on improving quality of care delivered,
and the vast changes occurring within the NHS, it is
vital to assess all components of quality [45]. Evaluating
the needs and preferences of service users is an import-
ant aspect in reviewing the quality of service delivered
[46,47]. Patient satisfaction serves as an essential deter-
minant of viability and sustainability of health care ser-
vices [48], and stockpiling of medications by patients
may be a strategy to prevent facing the rigours of orga-
nising a monthly prescription when situations are par-
ticularly difficult. While it is recommended that patient
satisfaction should be taken into account when designing
a repeat prescription service [14], the effect of flaws
within the system upon patient adherence has not been
previously identified. Aspects of the current system
within England are unlikely to change in the near future
as the current reimbursement schemes for community
pharmacies in England (fee per dispensed item) makes it
unlikely that lengthening repeat prescriptions would be
encouraged by pharmacists. Nevertheless, it has been es-
timated that even moving 50% of prescriptions from
28 days to 3 months in the 4 main chronic diseases
would reduce items dispensed by over 40 million, signifi-
cantly reducing system costs [39].
Pharmacies in England are undergoing further change,
as the Electronic Prescription Service release 2 (EPS2) is
due to be introduced [49]. This system will enable pre-
scribers to digitally sign and electronically transfer the
prescription to a national database, ‘The Spine’. The pre-
scriptions can then be downloaded and dispensed by a
pharmacy chosen by the patient. It is hoped that this will
optimise pharmacy processes, and improve organization;
for example being able to download prescriptions at the
start of business, and dispense prior to GP practices
opening. This would allow a smooth flow of dispensing
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pact on the patient experience will be of interest once
implemented.
The study we report has limitations in terms of being
confined to patients in just two primary care trusts. We
were also dependent on participants being recruited
through the actual services and have no information
about patients and carers who did not wish to take part
in the study. The focus of the study was not specifically
on repeat prescriptions and in the first phase of the
study we had not collected data from health profes-
sionals on their perspective of repeat prescriptions.
However, as this finding emerged inductively from pa-
tient and carer interviews we are confident of the valid-
ity of our findings, and that interviews were conducted
until data saturation had occurred with no new themes
arising [50].
Conclusion
While this study is limited in terms of the number of re-
search sites, it highlights a previously under-reported
area in an increasingly significant area of health spend-
ing. With an ageing population and associated morbid-
ities, a system change in repeat prescribing which would
not only reduce costs but also improve patient experi-
ence, appears overdue. There seems to be a clear case
for increasing routine repeat prescriptions to a longer
duration in terms of reducing costs and improving pa-
tient satisfaction, however further research is required to
explore how this would affect patient and carer burden,
and health outcomes.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PW conceived of the study and design, participated in data collection and
analysis, and helped draft the manuscript. NK participated in data analysis
and interpretation, and helped draft the manuscript. EM helped with data
collection, analysis and critically revising the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The study was funded by a NHS East of England clinical academic research
fellowship awarded to PW. Special thanks to Professor Martin Roland for
support and advice during the study and interpretation of data, Professor
Claire Goodman for advising on critical revision of the manuscript, and
Professor Sally Kendall’s general support as department chair.
Author details
1Centre for Research in Primary and Community Care, University of
Hertfordshire, College Lane, Hatfield AL10 9AB, UK. 2Princess Alexandra
Hospital NHS Trust, Hamstel Road, Harlow CM20 1QX, UK.
Received: 10 January 2013 Accepted: 20 May 2013
Published: 24 May 2013
References
1. World Health Organization: Preventing Chronic Diseases. A vital investment.
Geneva: WHO; 2005.2. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima
S, Feigl AB, Gaziano T, Mowafi M, Pandya A, et al: The Global Economic
Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
Geneva: World Economic Forum; 2011.
3. Singh D, Ham C: Improving care for people with long-term conditions.
Birmingham: NHS Institute for Innovation and Improvement, University of
Birmingham HSMC; 2006.
4. Milton JC, Hill-Smith I, Jackson SHD: Prescribing for older people. BMJ
2008, 336(7644):606–609.
5. Department of Health: Long Term Conditions. Compendium of Information.
3rd edition. London: Department of Health; 2012.
6. Department of Health: High Quality Care for All. London: Stationery Office; 2008.
7. Department of Health: Equity and Excellence: Liberating the NHS. London:
Department of Health; 2010.
8. Beishon J, McBride T, Scharaschkin A, Wilkins M, Mooney G, Nahal J, Paul P,
Wood D, Shapcott C: Prescribing costs in primary care. National Audit Office; 2007.
9. Avery T, Barber N, Ghaleb M, Franklin BD, Armstrong S, Crowe S, Dhillon S,
Freyer A, Howard R, Pezzolesi C et al.: Investigating the prevalence and causes
of prescribing errors in general practice. London: The General Medical
Council: PRACtICe Study; 2012.
10. Swinglehurst D, Greenhalgh T, Russell J, Myall M: Receptionist input to
quality and safety in repeat prescribing in UK general practice:
ethnographic case study. Br Med J 2011, 343(7831):d6788.
11. Steering Group on Improving the Use of Medicines: Improving the use of
medicines for better outcomes and reduced waste. An Action Plan. London:
Department of Health; 2012.
12. Morecroft CW, Ashcroft DM, Noyce P: Repeat dispensing of prescriptions
in community pharmacies: a systematic review of the UK literature. Int J
Pharm Pract 2006, 14:11–19.
13. De Smet AGM, Dautsenberg M: Repeat Prescribing: Scale, Problems and
Quality Management in Ambulatory Care Patients. Drugs 2004,
64(16):1779–1800.
14. National Prescribing Centre: Saving time, helping patients. A good practice
guide to quality repeat prescribing. Liverpool. National Prescribing Centre; 2004.
15. Dandridge J: Prescribing Points. NHS Oxfordshire 2005, 14.6:1–5.
16. White K: Medicines wastage: how big is the problem? 2009.
http://www.addisons.org.uk/comms/media/medicines_wastage.pdf:
accessed 23.05.13.
17. National Prescribing Centre: Dispensing with Repeats, A practical guide to repeat
dispensing. 2nd edition. Liverpool: National Prescribing Centre; 2008:1–32.
18. Holden J, Brown G: The introduction of repeat dispensing for 600
patients in one general practice. Int J Pharm Pract 2009, 17:249–251.
19. McGavock H, Wilson-Davis K, Connolly JP: Repeat prescribing
management - a cause for concern? Br J Gen Pract 1999, 49(442):343–347.
20. World Health Organization: Adherence to Long-Term Therapies: Evidence for
Action. Geneva: WHO; 2003.
21. Morgan TM: The economic impact of wasted prescription medication in
an outpatient population of older adults. J Fam Pract 2001, 50(9):779–781.
22. Zargarzadeh AH, Tavakoli N, Hassanzadeh A: A survey on the extent of
medication storage and wastage in urban Iranian households. Clin Ther
2005, 27(6):970–978.
23. Trueman P, Lowson K, Blighe A, Meszaros A, Wright D, Glanville J, Taylor D,
Newbold J, Bury M, Barber N, et al: Evaluation of the scale, causes and costs
of waste medicines. London: York Health Economics Consortium and School
of Pharmacy, University of London; 2010.
24. Abushanab AS, Sweileh WM, Wazaify M: Storage and wastage of drug
products in Jordanian households: a cross-sectional survey. Int J Pharm
Pract 2013, 21(3):185–191.
25. Europe RAND: Ernst &. National Evaluation of the Department of Health’s
Integrated Care Pilots: Young LLP; 2012.
26. Kendrick S, Conway M: Increasing emergency admissions among older people
in Scotland: a whole systems account. NHS Scotland: Information and
Statistics Division; 2003.
27. Wilson P: Patient experience in long-term conditions: revealing invisible
perspectives. Prim Health Care Res Dev 2011, 12(03):185–186.
28. Wilson P, Bunn F, Morgan J: A mapping of the evidence on integrated
long term condition services. Br J Community Nurs 2009, 14(5):202–206.
29. Ham C, Dixon J, Chantler C: Clinically integrated systems: the future of
NHS reform in England? Br Med J 2011, 342(7800):d905.
30. Department of Health: Research Governance Framework for Health and Social
Care (2nd ed). London: Department of Health; 2005.
Wilson et al. BMC Health Services Research 2013, 13:192 Page 11 of 11
http://www.biomedcentral.com/1472-6963/13/19231. Kvale S: An introduction to qualitative research interviewing. Thousand Oaks:
Sage; 1996.
32. Pope C, Ziebland S, Mays N: Analysing qualitative data. Br Med J 2000,
320:114–116.
33. Bazeley P: Qualitative Data Analysis with NVivo. London: Sage; 2007.
34. Glaser BG, Strauss AL: The Discovery of Grounded Theory: strategies for
qualitative research. Chicago: Aldine Publishing Company; 1967.
35. Lazarus R: Puzzles in the Study of Daily Hassles. J Behav Med 1984,
7(4):375–389.
36. Corbin J, Strauss A: Managing Chronic Illness at Home: Three Lines of
Work. Qual Sociol 1985, 8(3):224–247.
37. McGraw C, Drennan V: Older people and medication management: from
compliance to concordance. Rev Clin Gerontol 2004, 14(2):145–153.
38. Smith F, Francis S-A, Gray N, Denham M, Graffy J: A multi-centre survey
among informal carers who manage medication for older care
recipients: problems experienced and development of services. Health
Soc Care Community 2003, 11(2):138–145.
39. Kearney AT: The Future of Community Pharmacy in England. London: A.T.
Kearney; 2012.
40. White KG: UK interventions to control medicines wastage: a critical
review. Int J Pharm Pract 2010, 18(3):131–140.
41. Davies JE, Taylor DG: Individualisation or standardisation: trends in
National Health Service prescription durations in England 1998–2009.
Prim Health Care Res Dev 2013, 14(2):164–174.
42. O’Dowd A: Some PCTs recommend GPs limit prescriptions to 28 days.
Brit Med J 2011, 342:7803–d2410.
43. Addison’s Disease Support Group: Reforming prescription charges. 2009.
http://www.addisons.org.uk/comms/media/gilmore1.pdf: accessed 6.12.12.
44. Mitchell A, Hickey B, Hickey J, Pearce S: Trends in thyroid hormone
prescribing and consumption in the UK. BMC Publ Health 2009, 9(1):132.
45. The Health Foundation: Quality improvement training for healthcare
professionals. London: The Health Foundation; 2012.
46. Ford RC, Bach SA, Fottler MD: Methods of Measuring Patient Satisfaction
in Health Care Organizations. Health Care Manage Rev 1997, 22(2):74–89.
47. Batalden PDF: Teaching quality improvement: The devil is in the details.
JAMA 2007, 298(9):1059–1061.
48. Naik Panvelkar P, Saini B, Armour C: Measurement of patient satisfaction
with community pharmacy services: a review. Pharm World Sci 2009,
31(5):525–537.
49. Harvey J, Avery A, Waring J, Barber N: The socio-technical organisation of
community pharmacies as a factor in the Electronic Prescription Service
Release Two implementation: a qualitative study. BMC Health Serv Res
2012, 12(1):471.
50. Strauss A, Corbin J: Basics of Qualitative Research. Grounded Theory Procedures
and Techniques. Newbury Park, California: Sage Publications; 1990.
doi:10.1186/1472-6963-13-192
Cite this article as: Wilson et al.: Patient and carer experience of
obtaining regular prescribed medication for chronic disease in the
English National Health Service: a qualitative study. BMC Health Services
Research 2013 13:192.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
